Biolase, Inc
BIOLDelisted Sep 6, 2024- Industry
- Dental Equipment & Supplies
- SEC CIK
- 0000811240
Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Biolase, Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q2 2022
- Shares held
- 1.48M
- +89.3K (+6.4%) vs. Q2 2022
- Total value
- $3.58M
- −$2.76M (−43.5%) vs. Q2 2022
- New holders
- 1
- 8 more added
- Sold out
- 1
- 3 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1 |
| Q1 2026 | 1 | $1 |
| Q4 2025 | 1 | $1 |
| Q3 2025 | 1 | $1 |
| Q2 2025 | 1 | $1 |
| Q1 2025 | 1 | $1 |
| Q4 2024 | 1 | $1 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 2 | $1.94K |
| Q1 2024 | 18 | $116.1K |
| Q4 2023 | 16 | $335.6K |
| Q3 2023 | 12 | $199.2K |
| Q2 2023 | 29 | $311.8K |
| Q1 2023 | 27 | $1.49M |
| Q4 2022 | 25 | $445.8K |
| Q3 2022 | 24 | $3.58M |
| Q2 2022 | 25 | $6.34M |
| Q1 2022 | 37 | $6.17M |
| Q4 2021 | 50 | $6.85M |
| Q3 2021 | 47 | $14.4M |
| Q2 2021 | 42 | $12.4M |
| Q1 2021 | 41 | $14.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Biolase, Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 55 | $0 | 0.00% | +39+243.8% | Added |
| Wells Fargo & Company | 46 | $0 | 0.00% | +5+12.2% | Added |
| Royal Bank of Canada | 61 | $0 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 7 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 28 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 41 | $0 | 0.00% | +41 | New |
| American Portfolios Advisors | 16 | $39 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 2,141 | $2.00K | 0.00% | 00.0% | Unchanged |
| Orion Capital Management LLC | 2,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,961 | $5.00K | 0.00% | +670+51.9% | Added |
| UBS Group AG | 5,559 | $14.0K | 0.00% | +5,023+937.1% | Added |
| Morgan Stanley | 8,438 | $21.0K | 0.00% | −15,611−64.9% | Reduced |
| Northern Trust Corp | 11,230 | $27.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 17,440 | $42.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 17,549 | $43.0K | 0.00% | −8,268−32.0% | Reduced |
| Renaissance Technologies LLC | 18,848 | $46.0K | 0.00% | +600+3.3% | Added |
| Geode Capital Management, LLC | 54,924 | $133.0K | 0.00% | 00.0% | Unchanged |
| Essex Investment Management Co LLC | 105,318 | $256.0K | 0.04% | +40,440+62.3% | Added |
| BlackRock Inc. | 124,545 | $302.0K | 0.00% | −287−0.2% | Reduced |
| Perkins Capital Management Inc | 132,070 | $321.0K | 0.36% | +13,770+11.6% | Added |
| Vanguard Group Inc | 275,169 | $668.0K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 699,000 | $1.70M | 0.04% | +52,887+8.2% | Added |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Bivin & Associates, Inc. | – | – | – | – | Not filed |